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Assessment of Export Control Applicability: 
This Knowledge Capture event has been reviewed by the EC5 Spacesuit Knowledge Capture Manager in 
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YouTube viewing with download of any presentation material.  
Presenter: John James 
Synopsis: There have been a cluster of anecdotal reports that ISS crews are experiencing adverse health 
effects from on orbit exposure to CO2 levels well below the current Spacecraft Maximum Allowable 
Concentration (SMAC), which is 5.3 mmHg for 180 days of exposure. Developing evidence that this 
standard should be reduced to protect crew health is not a simple process. Dr. John James’ team looked 
at the reports of headaches by the crew during private medical conferences and matched these with 
CO2 levels around the time of these reports. They then compared these to CO2 levels when there were 
no reports of headache. Using benchmark dose modeling, they found that the risk of headache could be 
predicted in concentration ranges from 2 to 5 mmHg. However, the data are incomplete because there 
were insufficient data when crews were exposed to concentrations below 2 mmHg. James’ team also 
asked whether neuro-cognitive effects could be identified with CO2 exposure levels and found that 
these could not be associated with CO2 levels. Finally, they addressed the question of resource use to 
meet various levels of CO2 control if the SMACs were lowered. They estimated that CO2 restrictions 
approaching 2 mmHg would require substantial increases in power use and up-mass resources. They are 
refining their data on CO2 and headaches, and are looking at potential interactions of intracranial 
pressure and CO2 levels in eliciting ocular effects.  
Biography: Dr. John James earned a Ph.D. in pathology from the Graduate School of the University of 
Maryland School of Medicine in 1981 and has been a board-certified toxicologist since 1986. He came to 
https://ntrs.nasa.gov/search.jsp?R=20160014530 2019-08-29T17:01:46+00:00Z
JSC in 1989 and serves as the agency chief toxicologist. As such, he is responsible for air quality in 
human-rated spacecraft. His current research interests include the pulmonary toxicity of lunar dust, the 
interplay between intracranial pressure and high CO2 levels as they might affect crew health, and 
methods to discern health effects from exposures to mixtures of compounds.       
EC5 Spacesuit Knowledge Capture POCs: 




























L ki h d d f l i• oo ng a ea : near‐term an   or exp orat on
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Source (year set) Time Limit (%)
US Navy in NRC (2007) 90 d 0.5
NRC (2007) EEGL 1 h 2.5
EEGL 24 h 2.5
CEGL 90 d 0.8
NIOSH (2004)-REL Working lifetime 0.5
OSHA-PEL Working lifetime 0.5
NIOSH (2004)-IDLH brief 4.0
ACGIH (2004)-TLV Working lifetime 0.5  
ACGIH (2004)-STEL 15 min 3.0
SMAC (2008) 1 h 2.0 
SMAC (1996) 24 h 1.3  
SMACs (1996) 7-180d 0.7  
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Reality: Current ISS status with CO2: 6 
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Revision: Attempts to Associate Elevated CO2



































• Tried 5 benchmark dose models (3 ‘worked’)           
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Risk of Headache (%)
Δ Continuous Performance Task   
Δ CPT




to stunning doses of CO        2
• Humans with panic disorder (PD) respond 
differently to high levels of CO based on          2    
subtype
– Respiratory vs non‐respiratory PD patients  .      
– PD runs in families





as CO levels rise  2  
• In practical terms we try to operate with CO2






Looking Ahead‐Near Term   




fluid shifts and elevated CO exposure in causing        2      
ocular effects?
• Would more sophisticated behavioral studies of           
astronauts on orbit reveal an association 




practical CO2 management  .
• Explore differences in response to CO2 levels in the 
range from 2 to 8 mmHg using ground‐based model 
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